United States · 
Who invested in BackThorn Therapeutics?
BackThorn Therapeutics's investors include ARCH Venture Partners.
United States · Series A startup
Who invested in BackThorn Therapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2016, from 1 source
- Latest round
- Series A, $40MOct 2016
- Investors
- 1
The rounds
- Oct 2016
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about BackThorn Therapeutics
How much has BackThorn Therapeutics raised?
BackThorn Therapeutics has raised $40M across 1 round since 2016.
When did BackThorn Therapeutics last raise?
BackThorn Therapeutics's most recent round was a Series A of $40M in Oct 2016.
What was BackThorn Therapeutics's biggest round?
Its most recent round, $40M in Oct 2016, is also its largest on record.
Who backed BackThorn Therapeutics first?
BackThorn Therapeutics's first round on record, in Oct 2016, was backed by ARCH Venture Partners.
What stage is BackThorn Therapeutics at?
BackThorn Therapeutics's latest named round is a Series A, in Oct 2016.
Where is BackThorn Therapeutics based?
BackThorn Therapeutics is based in the United States.
Companies like BackThorn Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.